Cuprina Holdings (Cayman) Limited (CUPR)
| Market Cap | n/a |
| Revenue (ttm) | 54,541 |
| Net Income (ttm) | -745,973 |
| Shares Out | 21.75M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CUPR
Cuprina Holdings is a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We manufacture and distribute a line of medical grade sterile blowfly larvae bio-dressing pr... [Read more]
News
Singapore-based Cuprina Holdings, which makes wound care products, files for a $10 million US IPO
Cuprina Holdings, a Singapore-based provider of chronic wound care products, filed on Thursday with the SEC to raise up to $10 million in an initial public offering.
Cuprina Holdings IPO Registration Document (F-1)
Cuprina Holdings has filed to go public with an IPO on the NASDAQ.